Search

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the world, which can lead to considerably high mortality rate. It was reported that the prognosis is extremely poor and survival is often measured in months once CRC metastases become clinically evident. Therefore, the development of effective approach for metastatic CRC cells detection and imaging may potentially be significant and helpful for CRC prognosis and treatment. Therefore, we proposed a sensitive and specific approach for high-metastatic CRC LoVo cells detection and imaging by using terminal deoxynucleotidyl transferase (TdT)-initiated molecule beacons (MBs) arrayed fluorescent aptamer probes (denoted as TMAP). In this approach, the aptamer W3 targeting high-metastatic CRC LoVo cells was elongated to form W3-poly A at the 3′-hydroxyl terminus with repeated A bases in the presence of TdT and dATP. The MBs designed with poly T sequence in the loop were then hybridized with the poly A in the aptamer W3. The TMAP was easily constructed without the need of aptamer modification. It was demonstrated that this approach could specifically detect and image the high-metastatic CRC LoVo cells from the mixture of high-metastatic CRC LoVo cells and non-metastatic HCT-8 cells. Compared with 6-carboxyfluorescein (6-FAM) labeled aptamer W3, the TMAP was demonstrated to have a much stronger fluorescence signal on the target cells, realizing a 4-fold increase in signal-to-background ratio (SBR). Determination by flow cytometry allowed for detection of as low as 23 CRC LoVo cells in 200 μL cell culture medium. The high sensitivity and the capability for using in complicate biological samples imply that this approach holds considerable potential for metastatic CRC detection and therapy. Image 1 • TMAP was developed for specific detection and imaging of metastatic CRC cells. • TMAP could identify target LoVo cells with excellent binding affinity and specificity. • TMAP could specifically distinguish between the metastatic LoVo cells and non-metastatic HCT-8 cells in mixed cells samples. [ABSTRACT FROM AUTHOR]

Two different colors of water-soluble core-shell quantum dots CdTe/CdS (green and orange red) have been synthesized and characterized in this paper. The formation of core-shell quantum dots not only improves the fluorescence quantum yield, but also reduces the biological toxicity of quantum dots, and improves the fluorescence lifetime. Two novel fluorescent bioprobes, CdTe/CdS (λ em = 545 nm)-5-Fu and Bio-CdTe/CdS (λ em = 600 nm)-TAM, have been synthesized via the interaction of these two core-shell quantum dots with anticancer drugs (5-Fu) and P-gp inhibitors (TAM), respectively. These two fluorescent probes have been simultaneously used in fluorescence imaging of human breast cancer cells MDA-MB-231/MDR. It can be observed that under the action of P-gp inhibitors distributed on the cell membrane, anticancer drugs can be retained in cancer cells. According to the color of quantum dots on the probe, the visualization results of the action of anticancer drugs and P-gp inhibitors can be obtained. This study shows that to prepare functional bioprobes using core-shell quantum dots CdTe/CdS has great potential in the field of biomedical research such as anticancer drugs. Image 1 • CdTe/CdS core-shell QDs has higher fluorescence quantum yield and lower biological toxicity. • Simultaneous imaging of two bioprobes (CdTe/CdS-5-Fu, Bio-CdTe/CdS-TAM) in cancer cells. • Surface functionalization of quantum dots by anticancer drugs 5-Fu and P-gp inhibitors TAM. • Two colors bioprobes visualize the Interaction between Anticancer Drugs and P-gp Inhibitors. [ABSTRACT FROM AUTHOR]

Development of noninvasive bioimaging fluorescent probes for detecting particular enzyme activity is greatly recommendable for preclinical diagnosis of cancer. Given that the elevated β-gal activity is positively correlated with several tumors, developing a fluorescent probe for the sensing of β-gal is therefore highly desirable for cancer diagnosis. Herein, a new enzyme-activatable near-infrared (NIR) turn-on fluorescent probe (DMC-βgal) was developed for accurately detecting β-gal activity characterized by excellent selectivity, high sensitivity (LOD = 0.298 U/L), and low toxicity. More importantly, DMC-βgal qualifies remarkable NIR excitation (725 nm) and emission wavelength (770 nm), an ideal tool for restrained photodamage and suppressed autofluorescence. The above excellent performance of DMC-β-gal allowed for the accurate monitoring of endogenous β-gal in living cells. Moreover, the probe was successfully applied to detect intracellular β-gal activity in different types of cancer cells, verifying that SKOV-3 cells had a higher level of β-gal activity than those of A549, HCT-116, MCF-7, and HepG2 cells. Furthermore, DMC-βgal could real-time visualize endogenously β-gal in tumor-bearing nude mice with low auto-fluorescence interference. All results fully demonstrated that DMC-βgal has potential value as a promising strategy for diagnosis of β-gal-related diseases. [Display omitted] • A new near-infrared excited and emitted β-galactosidase (β-gal) fluorescent probe DMC-βgal was synthesized. • The probe DMC-βgal is characterized by excellent selectivity and high sensitivity (LOD = 0.298 U/L). • The probe is applied to prove that the β-gal activity in SKOV-3 cells is higher than HepG2, A549, HCT-116, MCF-7 cells. • DMC-βgal can real-time visualize the β-gal activity in tumor-bearing nude mice with low photodamage and autofluorescence. [ABSTRACT FROM AUTHOR]

Superoxide anion (O 2 •-) is an important biomarker for reactive oxygen species (ROS) generated through physiological and pathological processes. However, due to the short half-life of O 2 •- and high autofluorescence of cell tissues, in situ real-time tracking and monitoring of endogenous O 2 •- can be difficult. In this paper, a fluorescent probe IFP-O 2 was developed to detect endogenous O 2 •- in cells. The probe could instantaneously react with O 2 •- to produce fluorescence off-on effect; its detection limit was as low as 10 nM. Cell experiments also showed that the probe had low toxicity and mitochondrial targeting ability. The article presents, for the first time, a probe that can be employed to measure endogenous O 2 •- in oral cancer Cal-27 cells and is a promising tool for monitoring and evaluating apoptosis. Image 1 [ABSTRACT FROM AUTHOR]

Targeted imaging of cancer cells is crucial for early diagnosis. Mucin is a transmembrane protein that is overexpressed by cancer cells and is considered a cancer target. Specific recognition of mucin by aptamers has been receiving increasing attention in recent years. In this study, we use DNA MUC1 aptamer as a protective agent and target molecule in the synthesis of ultra-small fluorescent gold nanoclusters (MUC1-AuNCs) via a simple one-step method. MUC1-AuNCs exhibited red fluorescence emission with excellent stability over a wide pH range and under strong illumination. Confocal images showed that the synthesized MUC1-AuNCs efficiently targeted mucin overexpressing 4T1 cancer cells, but were not observed in 293T normal cells. Furthermore, the MUC1-AuNCs had a 5667 ns lifetime and 235 nm Stokes shifts and markedly eliminated background interference, suggesting they are a promising fluorescent probe for cell-targeted labeling and imaging. Image 1 • Luminescent gold nanoclusters were synthesized by thiolated MUC1 DNA aptamer as template. • The MUC1-AuNCs demonstrate good stability, low toxicity and specific cancer cell targeting properties. • The MUC1-AuNCs with long fluorescence lifetimes and large stokes shift can reduce background interference. [ABSTRACT FROM AUTHOR]